GNE-149 is an orally bioavailable full antagonist of estrogen receptor alpha (ERalpha, IC50=0.053 nM). GNE-149 is a selective estrogen receptor degrader (SERD). GNE-149 can be used for the research of breast cancer[1].
Molecular Weight:
503.57
Purity:
99.66
CAS Number:
[1953132-75-6]
Formula:
C28H33F4N3O
Target:
Estrogen Receptor/ERR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted